Integrated Core Strategies (Asia) Pte. Ltd. 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-30 4:36 pm Purchase | 2025-06-27 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (Asia) Pte. Ltd. | 4,717,215 5.600% | 3,348,194 (+244.57%) | Filing |
| 2023-01-23 4:31 pm Sale | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (Asia) Pte. Ltd. | 1,369,021 2.400% | -1,053,652 (-43.49%) | Filing |
| 2022-07-08 4:19 pm Purchase | 2022-07-01 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (Asia) Pte. Ltd. | 2,422,673 5.200% | 2,422,673 (New Position) | Filing |